# Panacea Biotec Ltd (PANACEABIO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹419.05
Day Change: +0.12%
52W High: ₹555.15
52W Low: ₹293.1
Market Cap: ₹2,370 Cr

## Valuation
P/E: 0
P/B: 2.87
EPS: ₹-1.28
Book Value: ₹134.77
Dividend Yield: 0%

## Returns
1Y Return: 4.86%

## Profitability
ROE: 0%
ROCE: -7.74%
Debt/Equity: 0.03
Revenue Growth: 1%
Profit Growth: -12.2%
EBITDA Margin: -4.83%
Operating Margin: 1.99%

## About
Panacea Biotec Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Panacea Biotec Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Details Of Shares Dematerialized During April 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
- Announcement: Intimation Of Fire Incident At Oncology Facility Of The Company'S Wholly Owned Subsidiary, Panacea Biotec Pharma Limited At Baddi, Himachal Pradesh
- BSE Filing: Details Of Shares Dematerialized During April 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-25T12:00:11.977Z
Price History Updated: 2026-05-25T05:31:33.519Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:31:33.519Z
Quant Updated: 2026-05-25T05:31:33.519Z
Sentiment Updated: 2026-05-25T05:31:33.519Z
Financials Status: current
Financials Updated: 2026-05-19T01:16:35.810Z
Financials Last Attempt: 2026-05-19T01:16:35.810Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹492.6 Cr
Operating Profit: ₹-55.61 Cr (OPM -11.29%)
Net Profit: ₹-8.37 Cr
Tax: ₹0.77 Cr

## Annual P&L History
FY25: Rev ₹492.6Cr | PAT ₹-8.37Cr | OPM -11.29%
FY24: Rev ₹551.93Cr | PAT ₹-1.17Cr | OPM -8.01%
FY23: Rev ₹456.92Cr | PAT ₹-33.24Cr | OPM -23.12%

## Balance Sheet (FY25)
Total Assets: ₹1289.75 Cr
Total Liabilities: ₹459.13 Cr
Borrowings: ₹15 Cr
Cash: ₹82.13 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rajesh  Jain Ph.D., Chairman of the Board & MD
- Sandeep  Jain, Joint MD & Executive Director
- Vinod  Goel, Group CFO and Head of Legal & Corporate Governance
- Khalid Al Syed, Chief Scientific Officer
- Gurinder Pal Singh, Senior Vice President of Sales

---
Source: rupiya.io/stocks/panaceabio
Disclaimer: For research and education only. Not investment advice.